Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome: a Prospective, Randomized, Open, Controlled Study
Latest Information Update: 27 Mar 2024
At a glance
- Drugs Semaglutide (Primary) ; Metformin
- Indications Infertility; Obesity; Polycystic ovary syndrome
- Focus Therapeutic Use
Most Recent Events
- 21 Mar 2024 Planned End Date changed from 31 Dec 2024 to 30 Jun 2025.
- 21 Mar 2024 Planned primary completion date changed from 30 Jun 2024 to 31 Dec 2024.
- 21 Mar 2024 Status changed from not yet recruiting to recruiting.